Tag Archives: Cessation

Joint Action by FDA and FTC Against Companies Marketing Unapproved Opioid Cessation Products

By Riëtte van Laack — On January 24, 2018, FDA and the Federal Trade Commission (FTC) posted joint warning letters to 11 marketers and distributors of opioid cessation products, alleging that those products were unapproved new drugs that violated the … Continue reading

Posted in Products Liability | Tagged , , , , , , , , | Leave a comment